Grant of options (3538D)
March 22 2011 - 3:00AM
UK Regulatory
TIDMIDOX
RNS Number : 3538D
IDOX PLC
22 March 2011
22 March 2011
IDOX PLC
Grant of options and directors' interests
IDOX announces that on 18 March 2011 options were granted,
pursuant to the unapproved share option scheme adopted by the Board
on 1 February 2007, to the below-noted directors following the
agreement of the terms of these options at the meetings of the
remuneration sub committees of the Board held on 15 March 2011 and
18 March 2011. Options have also been awarded to other members of
the management team as well as those members of the Board,
consistent with the Board's commitment to aligning shareholders,
the Board and senior executives' interests.
All options referred to are exercisable over ordinary shares of
1p each in the share capital of the Company ('Ordinary
Shares').
Director No. of options granted
Martin Brooks, Chairman 1,000,000
Richard Kellett-Clarke, Chief Executive
Officer 2,500,000
William Edmondson, Chief Financial
Officer 1,500,000
Christopher Wright, Non-Executive Director 250,000
Peter Lilley, Non-Executive Director 250,000
The options granted are subject to the following conditions:
Latest
# of Exercise Date Vesting Exercise
Director options price/p Granted Period Date
Quarterly
15 March over 3 14 March
Martin Brooks 1,000,000 20 2011 years 2021
Quarterly
Richard 15 March over 3 14 March
Kellett-Clarke 2,500,000 20 2011 years 2021
Quarterly
William 15 March over 3 14 March
Edmondson 1,500,000 20 2011 years 2021
Quarterly
Christopher 15 March over 3 14 March
Wright 250,000 20 2011 years 2021
Quarterly
15 March over 3 14 March
Peter Lilley 250,000 20 2011 years 2021
In addition to the share options above, the directors hold the
following beneficial interests in the share capital of the
Company:
Ordinary Shares % of issued share
Director Nature of Holding Held capital
Martin Brooks Direct 271,079 0.08
Martin Brooks Indirect 2,952,127 0.85
Richard
Kellett-Clarke Direct 2,818,181 0.81
Richard
Kellett-Clarke Indirect 1,616,667 0.46
Richard
Kellett-Clarke Indirect 1,200,000 0.35
William Edmondson Direct 100,000 0.03
Christopher Wright Direct 912,222 0.26
Peter Lilley Direct 533,000 0.15
In addition to the share options above, the following options
have already been granted to the Directors over Ordinary
Shares:
Latest
# of Exercise Date Vesting Exercise
Director options price/p Granted Period Date
Quarterly
Richard over 5
Kellett-Clarke 2,250,000 6.5 Feb 07 years Oct 2011
Quarterly
Richard over 3
Kellett-Clarke 2,250,000 9 Feb 07 years Oct 2014
Quarterly
Richard over 3
Kellett-Clarke 275,000 15 Dec 07 years Dec 2017
Quarterly
Richard over 5
Kellett-Clarke 769,231 13 Aug 08 years Aug 2018
Quarterly
Richard over 5
Kellett-Clarke 666,667 15 Aug 08 years Aug 2018
Quarterly
Richard over 3
Kellett-Clarke 2,439,024 10.25 Mar 10 years Mar 2020
Quarterly
over 3
Martin Brooks 2,250,000 6.5 Feb 07 years Oct 2011
Quarterly
over 3
Martin Brooks 2,250,000 9 Feb 07 years Oct 2014
Quarterly
over 3
Martin Brooks 275,000 15 Dec 07 years Dec 2017
Quarterly
over 5
Martin Brooks 423,077 13 Aug 08 years Aug 2018
Quarterly
over 5
Martin Brooks 366,667 15 Aug 08 years Aug 2018
Quarterly
over 3
Martin Brooks 975,610 10.25 Mar 10 years Mar 2020
Quarterly
William over 3
Edmondson 1,268,293 10.25 Mar 10 years Mar 2020
Quarterly
Christopher over 3
Wright 243,902 10.25 Mar 10 years Mar 2020
Quarterly
over 3
Peter Lilley 243,902 10.25 Mar 10 years Mar 2020
Enquiries:
IDOX
Martin Brooks, Chairman 020 7332 6000
Richard Kellett-Clarke, Chief Executive
Officer
William Edmondson, Chief Financial
Officer
Investec
Andrew Pinder / Patrick Robb / Dominic
Emery 020 7597 4000
College Hill
Adrian Duffield / Kay Larsen 020 7457 2020
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFIAVIILFIL
Idox (LSE:IDOX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Idox (LSE:IDOX)
Historical Stock Chart
From Jul 2023 to Jul 2024
